ASX · BIT.AX
Biotron Limited
A$0.00A$0.00 (0.0%)
Biotron Limited’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
Loading market information…
OTC · BNGI · USD
Stock price, dividends
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Bangi Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Bangi Inc.’s forward annual dividend is $3.10 per share, paid quarterly. The forward yield is 30,967,600.0% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Bangi Inc., headquartered in Grosse Pointe Farms, Michigan, focuses on sourcing and leasing a diverse array of properties specifically adapted for the cannabis sector. Its property portfolio includes cultivation sites for both hemp and cannabis, retail dispensary locations, and various commercial and industrial structures. Bangi Inc. operates as a subsidiary of Bangi Investments, LLC.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.00A$0.00 (0.0%)
Biotron Limited’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
$0.00$0.00 (0.0%)
American Green, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.67% below the high.
€0.03-€0.00 (-3.59%)
Biophytis S.A.’s quoted price sits in the lower half of its reported 52-week range, 79.75% below the high.
$0.00$0.00 (0.0%)
RespireRx Pharmaceuticals Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
$0.00$0.00 (0.0%)
Therapeutic Solutions International, Inc.: Healthcare · Biotechnology.
$0.01$0.00 (0.0%)
Viracta Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.8% below the high.
$0.02$0.00 (0.0%)
Imaging Dynamics Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.67% below the high.
$0.00$0.00 (0.0%)
Innovation Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.6% below the high.
